C. Santos, Affigen and M. May, CCRM.

(R-L) Carlos Santos, Ph.D., CEO of Affigen and Michael May, Ph.D., President & CEO of CCRM.

Format

JPEG

Centre for Commercialization of Regenerative Medicine (CCRM)